Cargando…

Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396634/
https://www.ncbi.nlm.nih.gov/pubmed/37538092
http://dx.doi.org/10.1155/2023/9824032
_version_ 1785083802905739264
author Markers, Disease
author_facet Markers, Disease
author_sort Markers, Disease
collection PubMed
description
format Online
Article
Text
id pubmed-10396634
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103966342023-08-03 Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury Markers, Disease Dis Markers Retraction Hindawi 2023-07-26 /pmc/articles/PMC10396634/ /pubmed/37538092 http://dx.doi.org/10.1155/2023/9824032 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Markers, Disease
Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
title Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
title_full Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
title_fullStr Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
title_full_unstemmed Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
title_short Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
title_sort retracted: network pharmacology and molecular docking-based investigation of potential targets of astragalus membranaceus and angelica sinensis compound acting on spinal cord injury
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396634/
https://www.ncbi.nlm.nih.gov/pubmed/37538092
http://dx.doi.org/10.1155/2023/9824032
work_keys_str_mv AT markersdisease retractednetworkpharmacologyandmoleculardockingbasedinvestigationofpotentialtargetsofastragalusmembranaceusandangelicasinensiscompoundactingonspinalcordinjury